Northern Trust’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $820K | Buy |
109,817
+71,759
| +189% | +$536K | ﹤0.01% | 3485 |
|
|
2025
Q1 | $372K | Buy |
38,058
+12,333
| +48% | +$120K | ﹤0.01% | 3691 |
|
|
2024
Q4 | $139K | Buy |
25,725
+10,472
| +69% | +$56.7K | ﹤0.01% | 4088 |
|
|
2024
Q3 | $95.9K | Sell |
15,253
-34,574
| -69% | -$217K | ﹤0.01% | 4068 |
|
|
2024
Q2 | $315K | Sell |
49,827
-12,270
| -20% | -$77.7K | ﹤0.01% | 3679 |
|
|
2024
Q1 | $509K | Buy |
62,097
+523
| +0.8% | +$4.29K | ﹤0.01% | 3559 |
|
|
2023
Q4 | $514K | Buy |
61,574
+6,887
| +13% | +$57.4K | ﹤0.01% | 3530 |
|
|
2023
Q3 | $705K | Buy |
54,687
+1,053
| +2% | +$13.6K | ﹤0.01% | 3406 |
|
|
2023
Q2 | $857K | Buy |
+53,634
| New | +$857K | ﹤0.01% | 3420 |
|